Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting

By In The News
March 25, 2019 in The Headlines

Recommended Posts

In The News

Posted March 25, 2019

- Share

Posted March 25, 2019

SYDNEY, March 25, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220081
2. Jaydee
  16881
3. Kip Powick
  12240
4. deicer
  12240
5. dagger
  9596
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.4k
- Total Posts
  
  559.3k

Sign In

Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support